When CSF biomarkers (α-synuclein, Aβ42, and total and phosphorylated tau proteins) were correlated with clinical features of more than 600 PPMI subjects at baseline, lower α-synuclein levels were found in patients with non-tremor dominant phenotype as compared to those with tremor-dominant phenotype [68]. This evidence concerns the gene SNCA and Tremor.